RA Capital Nexus Fund II, L.P., 10% Owner at AN2 Therapeutics, Inc. (ANTX), bought 142,848 shares at $7.97 ($1.1M) on 2022-06-14, disclosed to the SEC on 2022-06-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.90 | 20,000 | $158K | 13.9% |
| 2 | $7.97 | 61,424 | $490K | 43.1% |
| 3 | $7.97 | 61,424 | $490K | 43.1% |
| Total | $7.96 avg | 142,848 | $1.1M | 100% |
| Filing → |
| ANTX | BUY | 2023-08-22 | $16.0M | — | Filing → |
| JANX | BUY | 2023-07-21 | $12.3M | — | Filing → |
| DICE | BUY | 2023-03-30 | $29.6M | — | Filing → |